JBSS Q4 EPS $0.71 misses $1.20 estimate; sales beat
John B. Sanfilippo & Son reported Q4 FY26 diluted EPS of $0.71, missing the $1.20 estimate by 40.8%, while sales of $280.4 million beat the $274.9 million estimate by 2.0%. The earnings miss was driven by a 9.5% drop in gross profit due to recall costs and margin compression. Full-year sales rose 6.2% to $1.18 billion.

*this image is generated using AI for illustrative purposes only.
John B. Sanfilippo & Son, Inc. (NASDAQ: JBSS) reported fourth-quarter fiscal 2026 diluted earnings per share of $0.71, missing the analyst consensus estimate of $1.20 by 40.8%. Despite the earnings miss, net sales rose 4.2% to $280.4 million, beating the consensus estimate of $274.9 million by 2.0%.
The earnings shortfall reflects significant margin pressure in the quarter. While top-line growth was supported by an 8.9% annual increase in weighted average selling price, profitability contracted due to operational headwinds and a product recall.
Financial Performance
For the quarter ended June 25, 2026, gross profit decreased 9.5% to $44.1 million, with gross margin slipping from 18.1% to 15.7%. The decline was primarily driven by $2.7 million in recall-related costs associated with dry milk powder supplied by a third-party manufacturer. Additional pressures included higher customer claims, snack bar ingredient costs, manufacturing inefficiencies linked to onboarding a large contract manufacturing customer, and increased freight expenses.
Diluted earnings per share fell 38.3% to $0.71 from $1.15 in the prior-year period. Total operating expenses increased $3.1 million to $31.7 million, or 11.3% of net sales, up from 10.6% previously, due to higher incentive compensation and marketing spend, partially offset by an estimated insurance recovery related to the recall.
| Metric | Q4 FY26 | Q4 FY25 | Change |
|---|---|---|---|
| Net Sales | $280.4 million | $269.1 million | +4.2% |
| Gross Profit | $44.1 million | $48.8 million | -9.5% |
| Gross Margin | 15.7% | 18.1% | -240 bps |
| Diluted EPS | $0.71 | $1.15 | -38.3% |
Full Year Highlights
For the full fiscal year 2026, net sales increased 6.2% to $1.18 billion, driven by an 8.9% rise in weighted average selling price, which more than compensated for a 2.5% decrease in total sales volume. Full-year gross profit grew 3.8% to $211.2 million, while gross margin narrowed slightly from 18.4% to 18.0%. Diluted EPS for the full year increased 4.6% to $5.26.
The company’s inventory value decreased 3.4% to $245.8 million at quarter-end, reflecting lower finished goods for bars and reduced walnut acquisition costs, though pecan and almond costs rose. The weighted average cost per pound of raw nut and dried fruit input stock increased 12.1% year over year.
What the Numbers Show
The divergence between full-year top-line growth and fourth-quarter margin contraction highlights the impact of non-recurring operational disruptions. While the company successfully passed on commodity cost increases through an 8.9% annual price hike, the Q4 gross margin drop to 15.7%—well below the full-year average of 18.0%—was exacerbated by specific one-off charges. The $2.7 million recall cost alone represented approximately 6% of the quarterly gross profit, indicating that underlying operational margins were pressured further by input inflation and manufacturing inefficiencies before these exceptional items.
Leadership Transition and Shareholder Returns
Jeffrey T. Sanfilippo announced he will step down as CEO in October to become Executive Chairman, succeeded by his brother Jasper Sanfilippo. The company emphasized its commitment to shareholders, declaring a 5.6% increase in the annual dividend to $0.95 per share and a special dividend of $1.05 per share. Both will be paid on September 9, 2026, bringing total dividends for calendar year 2026 to $3.50 per share.
The company will host an investor conference call on Thursday, August 20, 2026, at 10:00 am Eastern time to discuss these results.
How will the transition of CEO leadership from Jeffrey to Jasper Sanfilippo impact JBSS's strategic direction and operational efficiency in the near term?
What specific measures is management implementing to resolve manufacturing inefficiencies associated with the new large contract manufacturing customer?
Given the 12.1% year-over-year increase in raw nut costs, can JBSS sustain its pricing power without further eroding sales volume?




























